GoAI
Get started
Myomo, Inc. logo

Myomo, Inc.

MYO

AMEXHealthcareMedical - Devices

Open in GoAI

Previous close

$1.73

−$0.01 · -0.57%

Aug 21, 4:00 PM ET

Pre-market

$1.68

−$0.05 · -2.89%

Aug 24, 6:32 AM ET

MYO company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

72

Undervalued

Momentum

52

Neutral

Sentiment

53

Mixed

Risk resilience

24

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
US
CEO
Paul R. Gudonis
Listed since
Jun 12, 2017
Employees
195

Market position

Day range

Current $1.73

52-week range

Current $1.73

Open
$1.78
Previous close
$1.74
Volume
1.09M
1.47× average
Average volume
737.91K
Average daily volume
Market cap
66.84M USD
Beta
1.44
Market reference 1
50-day average
$1.2196
+41.85% above average
200-day average
$0.9591
+80.39% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
43.34M USD
P/E (TTM)
-5.08×
P/B (TTM)
12.67×
P/S (TTM)
1.55×
EV / EBITDA
-3.5×
Earnings yield
-40.89%
Free cash flow yield
-42.67%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
68.35%
Operating margin
-27.05%
Net margin
-33.53%
Return on equity
-136.57%
Return on assets
-40.31%
Return on invested capital
-46.78%

Financial health

Debt / equity
3.44×
Current ratio
3.3×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends89%30%-30%-90%Gross margin, FY2021: 74.42%Gross margin, FY2022: 65.91%Gross margin, FY2023: 68.51%Gross margin, FY2024: 71.23%Gross margin, FY2025: 65.70%Operating margin, FY2021: -74.10%Operating margin, FY2022: -68.61%Operating margin, FY2023: -42.78%Operating margin, FY2024: -19.07%Operating margin, FY2025: -35.19%Net margin, FY2021: -74.86%Net margin, FY2022: -68.92%Net margin, FY2023: -42.34%Net margin, FY2024: -19.00%Net margin, FY2025: -38.05%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 74.42%. Gross margin FY2022 65.91%. Gross margin FY2023 68.51%. Gross margin FY2024 71.23%. Gross margin FY2025 65.70%. Operating margin FY2021 -74.10%. Operating margin FY2022 -68.61%. Operating margin FY2023 -42.78%. Operating margin FY2024 -19.07%. Operating margin FY2025 -35.19%. Net margin FY2021 -74.86%. Net margin FY2022 -68.92%. Net margin FY2023 -42.34%. Net margin FY2024 -19.00%. Net margin FY2025 -38.05%.

Income trends

Revenue

40.93M USD+25.73%

Operating income

−14.4M USD-132.04%

Net income

−15.57M USD-151.85%
Income trends across reported periods46.58M USD23.98M USD1.38M USD−21.22M USDRevenue, FY2021: 13.86M USDRevenue, FY2022: 15.56M USDRevenue, FY2023: 19.24M USDRevenue, FY2024: 32.55M USDRevenue, FY2025: 40.93M USDOperating income, FY2021: −10.27M USDOperating income, FY2022: −10.67M USDOperating income, FY2023: −8.23M USDOperating income, FY2024: −6.21M USDOperating income, FY2025: −14.4M USDNet income, FY2021: −10.37M USDNet income, FY2022: −10.72M USDNet income, FY2023: −8.15M USDNet income, FY2024: −6.18M USDNet income, FY2025: −15.57M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 13.86M USD. Revenue FY2022 15.56M USD. Revenue FY2023 19.24M USD. Revenue FY2024 32.55M USD. Revenue FY2025 40.93M USD. Operating income FY2021 −10.27M USD. Operating income FY2022 −10.67M USD. Operating income FY2023 −8.23M USD. Operating income FY2024 −6.21M USD. Operating income FY2025 −14.4M USD. Net income FY2021 −10.37M USD. Net income FY2022 −10.72M USD. Net income FY2023 −8.15M USD. Net income FY2024 −6.18M USD. Net income FY2025 −15.57M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue40.93M USD32.55M USD19.24M USD15.56M USD13.86M USD
Cost of goods sold14.04M USD9.37M USD6.06M USD5.3M USD3.54M USD
Gross profit26.89M USD23.19M USD13.18M USD10.25M USD10.31M USD
Research and development6.94M USD4.77M USD2.64M USD2.48M USD2.56M USD
Selling, general, and administrative34.35M USD24.62M USD18.78M USD18.44M USD18.02M USD
Operating expenses41.29M USD29.39M USD21.41M USD20.93M USD20.58M USD
Interest income476.97K USD388.59K USD410.27K USD88.73K USD1.61K USD
Interest expense927.8K USD————
Depreciation and amortization1.76M USD776.97K USD517.68K USD542.63K USD335.96K USD
Operating income−14.4M USD−6.21M USD−8.23M USD−10.67M USD−10.27M USD
Net income−15.57M USD−6.18M USD−8.15M USD−10.72M USD−10.37M USD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
-0.37
FY2025
Latest fiscal-year revenue
40.93M USD
FY2025 · +25.73% year over year
Next fiscal-year EPS consensus
-0.318
FY2026 · 2 analysts
Next fiscal-year revenue consensus
45.28M USD
FY2026 · 3 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend0-0.65-1.29-1.94FY21FY22FY23FY24FY25FY26FY27

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend59.8M43.09M26.39M9.68MFY21FY22FY23FY24FY25FY26FY27

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

8 ratings
Strong buy00%
Buy788%
Hold113%
Sell00%
Strong sell00%

Recent analyst actions

4 institutions
Lake StreetmaintainBuy

MYO news

marketbeat.com

Myomo Q2 Earnings Call Highlights

Myomo NYSEAMERICAN: MYO reported second-quarter 2026 revenue growth of 21% as the wearable robotics company continued shifting its patient acquisition strategy toward recurring referral sources and expanded reimbursement…

Read source
seekingalpha.com

Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript

Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript

Read source
zacks.com

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.11 per share a year ago.

Read source
businesswire.com

Myomo Reports Second Quarter 2026 Financial and Operating Results

BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological…

Read source
businesswire.com

Myomo to Report Second Quarter 2026 Financial Results on August 5

BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and…

Read source
seekingalpha.com

Myomo, Inc. (MYO) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript

Myomo, Inc. (MYO) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript

Read source

Corporate actions

Corporate action history

Stock split

Effective Jan 31, 2020

1:30

ETFs holding MYO

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
1.25M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
376.31K
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%

Continue in GoAI

Research MYO

research.disclaimer